117 related articles for article (PubMed ID: 10987990)
21. Endocannabinoids: a new class of vasoactive substances.
Randall MD; Kendall DA
Trends Pharmacol Sci; 1998 Feb; 19(2):55-8. PubMed ID: 9550942
[TBL] [Abstract][Full Text] [Related]
22. Endocannabinoid immune and vascular signaling.
Stefano GB
Acta Pharmacol Sin; 2000 Dec; 21(12):1071-81. PubMed ID: 11603279
[No Abstract] [Full Text] [Related]
23. Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells.
Mombouli JV; Schaeffer G; Holzmann S; Kostner GM; Graier WF
Br J Pharmacol; 1999 Apr; 126(7):1593-600. PubMed ID: 10323591
[TBL] [Abstract][Full Text] [Related]
24. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
25. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
Wagner JA; Varga K; Ellis EF; Rzigalinski BA; Martin BR; Kunos G
Nature; 1997 Dec; 390(6659):518-21. PubMed ID: 9394002
[TBL] [Abstract][Full Text] [Related]
26. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis.
Bátkai S; Járai Z; Wagner JA; Goparaju SK; Varga K; Liu J; Wang L; Mirshahi F; Khanolkar AD; Makriyannis A; Urbaschek R; Garcia N; Sanyal AJ; Kunos G
Nat Med; 2001 Jul; 7(7):827-32. PubMed ID: 11433348
[TBL] [Abstract][Full Text] [Related]
27. 2-Arachidonoylglycerol and the cannabinoid receptors.
Sugiura T; Waku K
Chem Phys Lipids; 2000 Nov; 108(1-2):89-106. PubMed ID: 11106784
[TBL] [Abstract][Full Text] [Related]
28. Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release.
Stefano GB
J Neuroimmunol; 1998 Mar; 83(1-2):70-6. PubMed ID: 9610675
[TBL] [Abstract][Full Text] [Related]
29. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
Zygmunt PM; Petersson J; Andersson DA; Chuang H; Sørgård M; Di Marzo V; Julius D; Högestätt ED
Nature; 1999 Jul; 400(6743):452-7. PubMed ID: 10440374
[TBL] [Abstract][Full Text] [Related]
30. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.
Kirkham TC; Williams CM; Fezza F; Di Marzo V
Br J Pharmacol; 2002 Jun; 136(4):550-7. PubMed ID: 12055133
[TBL] [Abstract][Full Text] [Related]
31. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
Sugiura T; Kishimoto S; Oka S; Gokoh M
Prog Lipid Res; 2006 Sep; 45(5):405-46. PubMed ID: 16678907
[TBL] [Abstract][Full Text] [Related]
32. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders.
Sipe JC; Arbour N; Gerber A; Beutler E
J Leukoc Biol; 2005 Jul; 78(1):231-8. PubMed ID: 15845647
[TBL] [Abstract][Full Text] [Related]
33. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
[TBL] [Abstract][Full Text] [Related]
34. A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells.
Rockwell CE; Raman P; Kaplan BL; Kaminski NE
Biochem Pharmacol; 2008 Aug; 76(3):353-61. PubMed ID: 18571623
[TBL] [Abstract][Full Text] [Related]
35. Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release.
Stefano GB; Salzet B; Rialas CM; Pope M; Kustka A; Neenan K; Pryor S; Salzet M
Brain Res; 1997 Jul; 763(1):63-8. PubMed ID: 9272829
[TBL] [Abstract][Full Text] [Related]
36. Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release.
Stefano GB; Salzet M; Bilfinger TV
J Cardiovasc Pharmacol; 1998 Jun; 31(6):862-8. PubMed ID: 9641470
[TBL] [Abstract][Full Text] [Related]
37. 2-arachidonylglycerol interacts with nitric oxide in the dorsomedial hypothalamus to increase food intake and body weight in young male rats.
McGavin JJ; Cochkanoff NL; Poole EI; Crosby KM
Neurosci Lett; 2019 Apr; 698():27-32. PubMed ID: 30615975
[TBL] [Abstract][Full Text] [Related]
38. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
[TBL] [Abstract][Full Text] [Related]
39. Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator?
Sugiura T; Kodaka T; Nakane S; Kishimoto S; Kondo S; Waku K
Biochem Biophys Res Commun; 1998 Feb; 243(3):838-43. PubMed ID: 9501013
[TBL] [Abstract][Full Text] [Related]
40. Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain.
Li B; Chen M; Guo L; Yun Y; Li G; Sang N
J Environ Sci (China); 2017 Jan; 51():265-274. PubMed ID: 28115138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
